معرفی
Inderjit Singh, MBChB, is an Associate Professor at Yale School of Medicine, specializing in Pulmonary, Critical Care & Sleep Medicine. He serves as the Director of the Pulmonary Vascular Disease Program and Program Director for the Advanced Fellowship in Pulmonary Vascular Disease. Dr. Singh is a specialist in pulmonary hypertension (high blood pressure in the heart-to-lung system) and leads one of the few centers worldwide that performs invasive cardiopulmonary exercise testing (iCPET) for patients with unexplained shortness of breath or fatigue.
Dr. Singh's educational background includes:
- Fellow, Pulmonary Vascular at Brigham and Women's Hospital (2018)
- Fellow, Pulmonary & Critical Care at New York Presbyterian - Weill Cornell Medical Center (2016)
- Residency in Internal Medicine at University of Pennsylvania (2013)
- Internship in Internal Medicine at University of Pennsylvania (2011)
- Residency and Internship in Internal Medicine at Beaumont Hospital, Dublin, Ireland (2010, 2008)
- MBChB and BMedSci from Royal College of Surgeons in Ireland (2007)
Dr. Singh's research focuses on understanding how the right ventricle of the heart and pulmonary circulation interact, particularly during exercise. His work explores the pathophysiology of pulmonary hypertension, with emphasis on exercise-induced abnormalities and the mechanisms underlying long COVID-related exercise intolerance. He has developed expertise in invasive cardiopulmonary exercise testing (iCPET), which allows for detailed hemodynamic assessment during physical exertion. His research has significant implications for understanding cardiopulmonary function in health and disease, particularly in conditions like pulmonary hypertension, heart failure, and post-COVID syndrome.
Dr. Singh's recent publications demonstrate a strong focus on pulmonary vascular mechanics, right heart function, and the application of advanced imaging and physiological testing methods. His work spans basic science investigations of pulmonary artery structure and function to clinical studies of cardiopulmonary exercise testing in various disease states. A notable theme is the investigation of how the proximal pulmonary artery regulates cardiopulmonary function, with particular attention to age-related changes and disease processes. His research integrates physiological measurements with advanced imaging techniques to provide comprehensive insights into cardiopulmonary pathophysiology.
Dr. Singh has received several prestigious awards for his work:
- Bronze award from Society of Critical Care Medicine (2024)
- Best abstract award from Society of Cardiovascular Anesthesiologists (2023)
- Best poster award from National Older Americans Independence Center (2023)
- Nomination for the Charles W. Bohmfalk Prize for teaching (2022)
- Best abstract award from Society of Cardiovascular Anesthesiologists (2022)
Dr. Singh is actively involved in clinical research, serving as a sub-investigator for multiple clinical trials including studies on pulmonary hypertension treatments. He is a dedicated educator who directs fellowship programs and mentors trainees in pulmonary vascular medicine. His laboratory work focuses on understanding the biomechanical properties of the pulmonary vasculature and their implications for cardiopulmonary function.
Dr. Singh leads the Pulmonary Vascular Disease Program at Yale, which focuses on the diagnosis and treatment of pulmonary hypertension and related conditions. The program performs specialized testing including invasive cardiopulmonary exercise testing, which is rare among medical centers worldwide. His team collaborates closely with experts in cardiology, radiology, and basic science to advance understanding of pulmonary vascular diseases.
